Nuzoa announces the official launch of the Biocera-Vet® line of bone substitutes – Diario Veterinario

by

After signing an exclusive distribution agreement for Spain of Theravet SA products in June, Nuzoa has announced that the complete line of Biocera-Vet® bone substitutes is now available for sale at Nuzoa. Theravet SA is a pioneer company in the treatment of osteoarticular diseases in pets and develops specific, safe and effective treatments to improve the quality of life of pets suffering from joint and bone diseases. It works closely with international opinion leaders to provide a more effective response to the growing needs in the field of veterinary medicine through innovative treatments.Biocera-Vet® is a complete range of innovative and easy-to-use bone substitutes. to use, efficient and profitable, indicated in bone surgeries where a bone graft is required and as a palliative alternative in the management of canine osteosarcoma. Biocera-Vet® has different product lines:Biocera-Vet® Bone Surgery RTU, self-hardening calcium phosphate cement. Biocera-Vet® Smartgraft, osteoconductive natural bone graft. Biocera-Vet® Granules, biocompatible calcium phosphate bone substitute. Biocera-Vet® Osteosarcoma RTU, ready-to-use, easily injectable calcium phosphate bone substitute for cementoplasty. For more information, you can contact your Nuzoa delegate or visit the website.